EWTX Reports $12M Q1 Rev, $0.00 EPS, Advances Sevasemten in Becker, EDG-7500 HCM Data Q2, GRAND CANYON Q4
Edgewise Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $40.26
-11% in 7d after detection
Post-detection moves
1h
—
1d
-0.7%
3d
-4.4%
7d
-11%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS